Business
Next Day Disclosure Return
Next Day Disclosure Return

About this update from Impact Therapeutics, Inc. Class H
Impact Therapeutics, Inc. Class H (7630) Press ReleaseView Attachment
View stock analysis, news, and events for Impact Therapeutics, Inc. Class H